Snapshot from Jun 09, 2026 at 07:00 UTC. For live data and tracking: View Live
Accidents disease outbreak

Bundibugyo Ebola Outbreak Spreads in Congo

Analysis based on 7 articles · First reported May 18, 2026 · Last updated May 20, 2026

Sentiment
-70
Attention
6
Articles
7
Market Impact
Direct
Live prominence charts, article sentiment distribution, and event development timeline available on the Ergen Dashboard

The Bundibugyo ebolavirus outbreak, for which there is no approved vaccine, poses a significant threat to global health and could negatively impact the healthcare and pharmaceutical industries. Companies involved in vaccine and therapeutic development for emerging infectious diseases may see increased attention, while those in affected regions like the Democratic Republic of the Congo and Uganda could face economic disruption.

Healthcare Pharmaceuticals Biotechnology

A deadly outbreak of the Bundibugyo ebolavirus is spreading in the Democratic Republic of the Congo and Uganda, prompting the World Health Organization to declare an international health emergency on May 17, 2026. This particular strain of Ebola has no approved vaccines or therapeutics, unlike the more common Zaire ebolavirus. The United States — Centers for Disease Control and Prevention is transferring exposed Americans from Congo and the United States has banned travelers from affected countries. The outbreak has already caused 246 suspected cases and 80 deaths in the Democratic Republic of the Congo's Ituri province and has reached Kampala, Uganda's capital. The delay in detection, due to rapid field tests calibrated for the Zaire ebolavirus, and the highly mobile population in conflict-ridden regions, are compounding the danger of widespread transmission.

95 World Health Organization declared emergency
75 United States expand travel ban
ngo
The World Health Organization declared the Bundibugyo virus outbreak an international health emergency and is actively involved in identifying the strain and coordinating response efforts.
Importance 95 Sentiment -20
cnt
The Democratic Republic of the Congo is experiencing a deadly outbreak of the Bundibugyo virus, which has led to 246 suspected cases and 80 deaths in its Ituri province. The ongoing conflict and humanitarian crisis in eastern Congo complicate containment efforts.
Importance 90 Sentiment -60
cnt
Uganda is also affected by the Bundibugyo virus outbreak, with cases reaching its capital city, Kampala. The virus was first identified in Uganda in 2007.
Importance 80 Sentiment -50
govactor
The United States — Centers for Disease Control and Prevention is transferring Americans exposed to the virus from Congo and has announced a ban on travelers from Ebola-affected countries. It assesses the risk to the United States as low.
Importance 70 Sentiment 0
cnt
The United States has implemented a travel ban from Ebola-affected countries and is evacuating its citizens exposed to the virus. The United States — Centers for Disease Control and Prevention states the risk to the United States remains low.
Importance 60 Sentiment -10
cnt
Germany has received an American doctor evacuated from Congo due to high-risk exposure to the Bundibugyo virus.
Importance 30 Sentiment 0
cnt
South Sudan shares porous borders with the Democratic Republic of the Congo's Ituri province, increasing the risk of the Bundibugyo ebolavirus spreading.
Importance 20 Sentiment -10
per
Klinger Soares Faico Filho is an infectious disease scientist who provides expert analysis on the Bundibugyo ebolavirus outbreak, agreeing that the risk to the United States is low but highlighting the lack of a vaccine for this strain.
Importance 10 Sentiment 0
oth
Klinger Soares Faico Filho, a professor at Federal University of São Paulo, contributed expert analysis to the article.
Importance 5 Sentiment 0
NEWSDESK
Track this event live

Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.

Open Dashboard

About Ergen

Ergen is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.ergen.ai.